AHCO — ADAPTHEALTH CORP
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ADAPTHEALTH CORP (AHCO)
ADAPTHEALTH CORP (AHCO) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $8M. Across recent filings, tracked investors recorded 4 new positions, 1 increased, 1 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in AHCO
How many top investors track AHCO
A small number of top investors own this.
AHCO Ownership Composition
How ADAPTHEALTH CORP is held across tracked investor types, based on reported 13F positions.
- Other92.2%
- Hedge Funds7.8%
Tracked investors reporting AHCO
- Izzy EnglanderMar 31, 2026Millennium ManagementShares661.2KValue$7.9M% Portfolio0.00%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares230.4KValue$2.7M% Portfolio0.00%
- Steve CohenDec 31, 2025Point72 Asset ManagementShares90.2KValue$898.4K% Portfolio0.00%
Recent activity
- $5.5MFeb 17, 2026
- $7.9MMay 15, 2026
- New$898.4KFeb 17, 2026
- Reduced$2.7M(-51.50%)May 15, 2026
- Increased$4.7M(7.04%)Feb 17, 2026
- New$4MNov 14, 2025
Frequently asked questions
- How many institutional investors hold AHCO?
- 3 tracked institutional investors disclosed a position in AHCO (ADAPTHEALTH CORP) in their most recent 13F filing.
- Who is the largest institutional holder of AHCO?
- Izzy Englander, Millennium Management, holds the largest disclosed position in AHCO, valued at $8M.
- Did institutional ownership of AHCO increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 1 increased, 1 reduced, and 0 fully exited AHCO.
- Where does this AHCO ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.